Physicians' Academy for Cardiovascular Education

Colchicine reduces primary outcome in chronic coronary disease

3' education - Aug. 31, 2020 - Mark Nidorf, MD - Perth, Australia

Educational information

This video was recorded during the virtual congress of the ESC 2020.


Mark Nidorf, MD - cardiologist, Perth, Australia


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Read our summary of the LoDoCo2 trial

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: